Butyrate differentiates permissiveness to Clostridioides difficile infection and influences growth of diverse C. difficile isolates

• Published in: bioRxiv
• Main Authors: Pensinger, Daniel, Fisher, Andrea T, Dobrila, Horia A, Will Van Treuren, Gardner, Jackson O, Higginbottom, Steven K, Carter, Matthew M, Schumann, Benjamin, Bertozzi, Carolyn, Anikst, Victoria, Cody, Martin, Robilotti, Elizabeth, Chow, Jomay, Buck, Rachael H, Tompkins, Lucy S, Sonnenburg, Justin L, Hryckowian, Andrew J
• Format: Paper
• Language: English
• Published: Cold Spring Harbor Cold Spring Harbor Laboratory Press 21.05.2022
• Subjects: Acetic acid; Animal models; Antibiotics; Carbohydrates; Clostridioides difficile; Diarrhea; Diet; Digestive system; Fatty acids; Feces; Fitness; Gastrointestinal tract; Intestinal microflora; Metabolism; Metabolites; Microbiomes; Microbiota; Pathogens; Propionic acid
• DOI: 10.1101/2022.05.20.492898

A disrupted "dysbiotic" gut microbiome engenders susceptibility to the diarrheal pathogen Clostridioides difficile by impacting the metabolic milieu of the gut. Diet, in particular the microbiota accessible carbohydrates (MACs) found in dietary fiber, is one of the most powerful ways to affect the composition and metabolic output of the gut microbiome. As such, diet is a powerful tool for understanding the biology of C. difficile and for developing alternative approaches for coping with this pathogen. One prominent class of metabolites produced by the gut microbiome are short chain fatty acids (SCFAs), the major metabolic end products of MAC metabolism. SCFAs are known decrease the fitness of C. difficile in vitro and that high intestinal SCFA concentrations are associated with reduced fitness of C. difficile in animal models of C. difficile infection (CDI). Here, we use controlled dietary conditions (8 diets that differ only by MAC composition) to show that C. difficile fitness is most consistently impacted by butyrate, rather than the other two prominent SCFAs (acetate and propionate), during murine model CDI. We similarly show that butyrate concentrations are lower in fecal samples from humans with CDI relative to healthy controls. Finally, we demonstrate that butyrate impacts growth in diverse C. difficile isolates. These findings provide a foundation for future work which will dissect how butyrate directly impacts C. difficile fitness and will lead to the development of diverse approaches distinct from antibiotics or fecal transplant, such as dietary interventions, for mitigating CDI in at-risk human populations.